Regencell Bioscience Holdings Limited (RGC)
NASDAQ: RGC · Real-Time Price · USD
19.45
-0.60 (-2.99%)
Oct 8, 2025, 12:02 PM EDT - Market open
RGC Market Cap
RGC has a market cap or net worth of $9.62 billion as of October 8, 2025. Its market cap has increased by 11,659.80% in one year.
Market Cap
9.62B
Enterprise Value
9.91B
1-Year Change
11,659.80%
Ranking
Category
Stock Price
$19.45
Market Cap Chart
Since the IPO on July 16, 2021, RGC's market cap has increased from $120.10M to $9.62B, an increase of 7,908.17%. That is a compound annual growth rate of 181.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 9.91B | 15,323.08% |
| Dec 31, 2024 | 64.28M | -52.95% |
| Dec 29, 2023 | 136.63M | -62.35% |
| Dec 29, 2022 | 362.93M | -12.12% |
| Dec 31, 2021 | 413.00M | 243.88% |
| Jul 16, 2021 | 120.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |